List of Excipients in API amlodipine besylate and benazepril hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing amlodipine besylate and benazepril hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | LOTREL | amlodipine besylate and benazepril hydrochloride | 0078-0405 | CALCIUM PHOSPHATE | |
| Novartis Pharmaceuticals Corporation | LOTREL | amlodipine besylate and benazepril hydrochloride | 0078-0405 | CROSPOVIDONE | |
| Novartis Pharmaceuticals Corporation | LOTREL | amlodipine besylate and benazepril hydrochloride | 0078-0405 | FERRIC OXIDE RED | |
| Novartis Pharmaceuticals Corporation | LOTREL | amlodipine besylate and benazepril hydrochloride | 0078-0405 | GELATIN | |
| Novartis Pharmaceuticals Corporation | LOTREL | amlodipine besylate and benazepril hydrochloride | 0078-0405 | HYDROGENATED CASTOR OIL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing amlodipine besylate and benazepril hydrochloride
Detailed excipient profiles for amlodipine besylate and benazepril hydrochloride
Excipient focus: ANHYDROUS LACTOSE
amlodipine besylate and benazepril hydrochloride drug variants containing ANHYDROUS LACTOSE
amlodipine besylate and benazepril hydrochloride drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM PHOSPHATE
amlodipine besylate and benazepril hydrochloride drug variants containing CALCIUM PHOSPHATE
amlodipine besylate and benazepril hydrochloride drug variants not containing CALCIUM PHOSPHATE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
amlodipine besylate and benazepril hydrochloride drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | amlodipine besylate and benazepril hydrochloride | 63629-5366 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and benazepril hydrochloride drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CELLULOSE, MICROCRYSTALLINE
amlodipine besylate and benazepril hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
amlodipine besylate and benazepril hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
amlodipine besylate and benazepril hydrochloride drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | amlodipine besylate and benazepril hydrochloride | 54868-6297 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and benazepril hydrochloride drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSPOVIDONE
amlodipine besylate and benazepril hydrochloride drug variants containing CROSPOVIDONE
amlodipine besylate and benazepril hydrochloride drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
amlodipine besylate and benazepril hydrochloride drug variants containing D&C RED NO. 28
amlodipine besylate and benazepril hydrochloride drug variants not containing D&C RED NO. 28
Excipient focus: D&C YELLOW NO. 10
amlodipine besylate and benazepril hydrochloride drug variants containing D&C YELLOW NO. 10
amlodipine besylate and benazepril hydrochloride drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
amlodipine besylate and benazepril hydrochloride drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | amlodipine besylate and benazepril hydrochloride | 69097-143 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and benazepril hydrochloride drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FD&C BLUE NO. 1
amlodipine besylate and benazepril hydrochloride drug variants containing FD&C BLUE NO. 1
amlodipine besylate and benazepril hydrochloride drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
amlodipine besylate and benazepril hydrochloride drug variants containing FD&C BLUE NO. 2
amlodipine besylate and benazepril hydrochloride drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C GREEN NO. 3
amlodipine besylate and benazepril hydrochloride drug variants containing FD&C GREEN NO. 3
amlodipine besylate and benazepril hydrochloride drug variants not containing FD&C GREEN NO. 3
Excipient focus: FD&C RED NO. 40
amlodipine besylate and benazepril hydrochloride drug variants containing FD&C RED NO. 40
amlodipine besylate and benazepril hydrochloride drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
amlodipine besylate and benazepril hydrochloride drug variants containing FD&C YELLOW NO. 6
amlodipine besylate and benazepril hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
amlodipine besylate and benazepril hydrochloride drug variants containing FERRIC OXIDE RED
amlodipine besylate and benazepril hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
amlodipine besylate and benazepril hydrochloride drug variants containing FERRIC OXIDE YELLOW
amlodipine besylate and benazepril hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
amlodipine besylate and benazepril hydrochloride drug variants containing FERROSOFERRIC OXIDE
amlodipine besylate and benazepril hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
amlodipine besylate and benazepril hydrochloride drug variants containing GELATIN
amlodipine besylate and benazepril hydrochloride drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROGENATED CASTOR OIL
amlodipine besylate and benazepril hydrochloride drug variants containing HYDROGENATED CASTOR OIL
amlodipine besylate and benazepril hydrochloride drug variants not containing HYDROGENATED CASTOR OIL
Excipient focus: HYPROMELLOSE
amlodipine besylate and benazepril hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and benazepril hydrochloride | 0078-0405 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and benazepril hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
amlodipine besylate and benazepril hydrochloride drug variants containing HYPROMELLOSES
amlodipine besylate and benazepril hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
amlodipine besylate and benazepril hydrochloride drug variants containing LACTOSE
amlodipine besylate and benazepril hydrochloride drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
amlodipine besylate and benazepril hydrochloride drug variants containing LACTOSE MONOHYDRATE
amlodipine besylate and benazepril hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
amlodipine besylate and benazepril hydrochloride drug variants containing MAGNESIUM STEARATE
amlodipine besylate and benazepril hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
amlodipine besylate and benazepril hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | amlodipine besylate and benazepril hydrochloride | 69097-143 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and benazepril hydrochloride drug variants not containing MANNITOL
Excipient focus: POLYETHYLENE GLYCOL 400
amlodipine besylate and benazepril hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | amlodipine besylate and benazepril hydrochloride | 49884-929 |
| Bryant Ranch Prepack | amlodipine besylate and benazepril hydrochloride | 63629-4878 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and benazepril hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYSORBATE 80
amlodipine besylate and benazepril hydrochloride drug variants containing POLYSORBATE 80
amlodipine besylate and benazepril hydrochloride drug variants not containing POLYSORBATE 80
Excipient focus: POTASSIUM HYDROXIDE
amlodipine besylate and benazepril hydrochloride drug variants containing POTASSIUM HYDROXIDE
amlodipine besylate and benazepril hydrochloride drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
amlodipine besylate and benazepril hydrochloride drug variants containing POVIDONE
amlodipine besylate and benazepril hydrochloride drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
amlodipine besylate and benazepril hydrochloride drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | amlodipine besylate and benazepril hydrochloride | 33261-982 |
| Bryant Ranch Prepack | amlodipine besylate and benazepril hydrochloride | 63629-5366 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and benazepril hydrochloride drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
amlodipine besylate and benazepril hydrochloride drug variants containing PROPYLENE GLYCOL
amlodipine besylate and benazepril hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
amlodipine besylate and benazepril hydrochloride drug variants containing SHELLAC
amlodipine besylate and benazepril hydrochloride drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
amlodipine besylate and benazepril hydrochloride drug variants containing SILICON DIOXIDE
amlodipine besylate and benazepril hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | amlodipine besylate and benazepril hydrochloride | 54868-6297 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
amlodipine besylate and benazepril hydrochloride drug variants containing SODIUM LAURYL SULFATE
amlodipine besylate and benazepril hydrochloride drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
amlodipine besylate and benazepril hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
amlodipine besylate and benazepril hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
amlodipine besylate and benazepril hydrochloride drug variants containing STARCH, CORN
amlodipine besylate and benazepril hydrochloride drug variants not containing STARCH, CORN
Excipient focus: TALC
amlodipine besylate and benazepril hydrochloride drug variants containing TALC
amlodipine besylate and benazepril hydrochloride drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
amlodipine besylate and benazepril hydrochloride drug variants containing TITANIUM DIOXIDE
amlodipine besylate and benazepril hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | amlodipine besylate and benazepril hydrochloride | 50090-6427 |
| REMEDYREPACK INC | amlodipine besylate and benazepril hydrochloride | 70518-2566 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
